Home > Journals > Minerva Medica > Past Issues > Minerva Medica 2010 February;101(1) > Minerva Medica 2010 February;101(1):9-23

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA MEDICA

A Journal on Internal Medicine


Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,236


eTOC

 

ORIGINAL ARTICLES  THROMBOSIS FORUM


Minerva Medica 2010 February;101(1):9-23

language: English

Drug-eluting stents: limitations of early generation and progress with newer generation devices

Khattab A. A., Windecker S.

Department of Cardiology, Bern University Hospital, Bern, Switzerland


PDF  


The success of first generation drug-eluting stents, namely by reducing restenosis and the need of repeat revascularization procedures is hampered by some limitations affecting device safety. Intense research efforts helped to identify these shortcomings and direct research to develop newer generation drug-eluting stents with the potential to circumvent these drawbacks. This review will discuss limitations of early generation drug-eluting stents, focus on solutions provided by newer generation devices, and shed light on unresolved issues and potential future solutions.

top of page

Publication History

Cite this article as

Corresponding author e-mail

stephan.windecker@insel.ch